Published in Eur J Clin Invest on March 01, 2006
Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. Biochem Pharmacol (2009) 1.49
Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab (2007) 1.27
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol (2012) 1.27
Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med (2009) 1.24
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr Rev (2012) 1.11
Identification of ALOX5 as a gene regulating adiposity and pancreatic function. Diabetologia (2008) 1.10
Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am J Clin Nutr (2008) 1.10
Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigenetics. J Nutrigenet Nutrigenomics (2009) 1.01
Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice. Proc Natl Acad Sci U S A (2012) 0.98
Genetic contribution of the leukotriene pathway to coronary artery disease. Hum Genet (2011) 0.96
Effects of MK-886, a 5-lipoxygenase activating protein (FLAP) inhibitor, and 5-lipoxygenase deficiency on the forced swimming behavior of mice. Neurosci Lett (2008) 0.95
Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3. Physiol Genomics (2011) 0.89
Leukotrienes as modifiers of preclinical atherosclerosis? ScientificWorldJournal (2012) 0.84
Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions. J Cardiovasc Transl Res (2013) 0.84
The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol (2015) 0.81
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males. J Clin Invest (2017) 0.79
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. Eur J Clin Pharmacol (2017) 0.78
Association of PLA2G4A with myocardial infarction is modulated by dietary PUFAs. Am J Clin Nutr (2012) 0.78
5-(4-Hydroxy-2,3,5-trimethylbenzylidene) thiazolidine-2,4-dione attenuates atherosclerosis possibly by reducing monocyte recruitment to the lesion. Exp Mol Med (2011) 0.77
The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis. Med Sci Monit (2012) 0.76
Common Polymorphisms in the 5-Lipoxygenase Pathway and Risk of Incident Myocardial Infarction: A Danish Case-Cohort Study. PLoS One (2016) 0.75
NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance. Sci Rep (2016) 0.75
Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases. Mediators Inflamm (2017) 0.75
Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol (2003) 2.89
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med (2006) 2.70
Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig. Prostaglandins (1975) 2.45
Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol (2006) 2.21
Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature (1978) 2.10
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med (1990) 2.06
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest (2001) 1.95
Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun (2000) 1.94
Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Kidney Int (2007) 1.80
Mouse models of experimental atherosclerosis. J Physiol Pharmacol (2004) 1.68
Prostacyclin is a circulating hormone. Nature (1978) 1.60
Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1990) 1.54
Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet (1978) 1.53
The role of proinflammatory cytokines in the generation and maintenance of joint pain. Ann N Y Acad Sci (2010) 1.46
On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol (1987) 1.43
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol (2007) 1.42
Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene (2008) 1.40
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene (2007) 1.37
Synthesis and thrombolytic activity of new thienopyrimidinone derivatives. J Physiol Pharmacol (2002) 1.35
Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system. Eur J Clin Invest (2006) 1.26
Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment. J Intern Med (2004) 1.26
Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Mol Endocrinol (2000) 1.22
Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene (2010) 1.19
Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J Intern Med (2011) 1.17
In vivo method for quantitation for anti-platelet potency of drugs. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.17
Randomised clinical trial: The ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation--a double-blind study. Aliment Pharmacol Ther (2011) 1.16
Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol (2002) 1.16
Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci U S A (1990) 1.15
Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest (2005) 1.14
The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors. Br J Pharmacol (1990) 1.11
Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J Physiol Pharmacol (2007) 1.08
Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol (2005) 1.06
Diffusion-weighted imaging (DWI) in MR mammography (MRM): clinical comparison of echo planar imaging (EPI) and half-Fourier single-shot turbo spin echo (HASTE) diffusion techniques. Eur Radiol (2009) 1.05
Lipopolysaccharide increases release of a nitric oxide-like factor from endothelial cells. Eur J Pharmacol (1989) 1.04
Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy. Thromb Res (1978) 1.04
Bile acid synthesis in primary cultures of rat and human hepatocytes. Hepatology (1998) 1.03
Association of the presence of Helicobacter pylori in the oral cavity and in the stomach. J Physiol Pharmacol (2004) 1.02
Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J Intern Med (2013) 1.02
Surgical management of multiple bilateral fibroadenoma of the breast: the Ribeiro technique modified by Rezai. Anticancer Res (2009) 1.00
Hepatic cholesterol metabolism in human obesity. Hepatology (1997) 0.99
Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res (1990) 0.98
Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction. Eur J Clin Invest (2008) 0.98
A system of periventricular glia in brain characterized by large peroxisome-like cell organelles. Acta Histochem (1971) 0.98
Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation (2001) 0.97
Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Br J Pharmacol (1990) 0.97
Prolactin--not only lactotrophin. A "new" view of the "old" hormone. J Physiol Pharmacol (2012) 0.96
Selective inhibition of thromboxane A2 biosynthesis in blood platelets. Nature (1977) 0.95
Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum. Gastroenterology (1991) 0.95
Helicobacter pylori in the oral cavity and its implications for gastric infection, periodontal health, immunology and dyspepsia. J Physiol Pharmacol (2005) 0.94
Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma. J Clin Invest (1989) 0.94
[Evaluation of a cell block method in cytological diagnostics]. Pathologe (2012) 0.94
Lipoprotein metabolism in the fat Zucker rat: reduced basal expression but normal regulation of hepatic low density lipoprotein receptors. Endocrinology (1997) 0.93
Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era? Curr Opin Lipidol (1999) 0.92
Effects of novel plant antioxidants on platelet superoxide production and aggregation in atherosclerosis. J Physiol Pharmacol (2006) 0.92
Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues. J Biol Inorg Chem (2010) 0.92
Hepatic cholesterol metabolism in estrogen-treated men. Gastroenterology (1992) 0.92
Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism. Eur J Clin Pharmacol (1991) 0.91
Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. Rofo (2011) 0.91
Optical-digital method of local histogram calculation by threshold decomposition. Appl Opt (1993) 0.90
Endothelins release tissue plasminogen activator and prostanoids. Eur J Pharmacol (1990) 0.90
Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest (1989) 0.89
Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodilators. Lancet (1990) 0.89
Dialysis for psoriasis - preliminary remarks concerning mode of action. Arch Dermatol Res (1981) 0.88
Atheroprotective effect of adjuvants in apolipoprotein E knockout mice. Atherosclerosis (2005) 0.88
Fibrinolytic activity of 6-keto-prostaglandin E1. Thromb Haemost (1983) 0.87
Hypercholesterolemia does not alter endothelial function in spontaneously hypertensive rats. J Pharmacol Exp Ther (2006) 0.87
Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis. Cell Mol Biol (Noisy-le-grand) (2007) 0.87
Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression. Biochem J (1996) 0.87
Hypocholesterolemia in cancer patients may be caused by elevated LDL receptor activities in malignant cells. Med Oncol Tumor Pharmacother (1985) 0.87
The current view on the role of leukotrienes in atherogenesis. J Physiol Pharmacol (2010) 0.87
[Diagnosis and treatment of necrotizing fasciitis of the head and neck region]. Laryngorhinootologie (2000) 0.86
Novel effects of histamine on lipoprotein metabolism: suppression of hepatic low density lipoprotein receptor expression and reduction of plasma high density lipoprotein cholesterol in the rat. Endocrinology (1997) 0.86
Efficacy control of therapy using circulating epithelial tumor cells (CETC) as "liquid biopsy": trastuzumab in HER2/neu-positive breast carcinoma. J Cancer Res Clin Oncol (2011) 0.86
Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase. Hepatology (1995) 0.86
Kaempferol, but not resveratrol inhibits angiotensin converting enzyme. J Physiol Pharmacol (2008) 0.86
The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice. J Physiol Pharmacol (2008) 0.86
Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart. Prostaglandins Leukot Essent Fatty Acids (2005) 0.85
Influence of middle-sized molecule aggregates from dialysate of uremic patients on lymphocyte transformation in vitro. Nephron (1976) 0.85
Inhibition of nuclear factor-kappaB attenuates artherosclerosis in apoE/LDLR - double knockout mice. J Physiol Pharmacol (2005) 0.85
Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis. Ann Rheum Dis (2009) 0.84
Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells. J Physiol Pharmacol (2002) 0.84
Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler Thromb Vasc Biol (1999) 0.84
Superoxide dismutase activity and expression in human venous and arterial bypass graft vessels. J Physiol Pharmacol (2005) 0.84
Placental Schistosoma haematobium infection in a German returnee from Malawi. Infection (2014) 0.84
Angiotensin-(1-7) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice. J Physiol Pharmacol (2012) 0.83
The mechanisms of antimacrophage serum-induced fusion of hamster macrophages. Acta Histochem (1972) 0.83
Respiratory movements alter the generation of prostacyclin and thromboxane A2 in isolated rat lungs: the influence of arachidonic acid-pathway inhibitors on the ratio between pulmonary prostacyclin and thromboxane A2. Prostaglandins (1981) 0.83
Ischaemic cardiac hyperaemia: role of nitric oxide and other mediators. Physiol Res (1996) 0.83